Drug testing data from the 2007 Pan American Games: δ 13C values of urinary androsterone, etiocholanolone and androstanediols determined by GC/C/IRMS

Journal of Steroid Biochemistry and Molecular Biology

Volumn 115, Issue 3-5, 2009, Pages 107-114

  Aguilera, Rodrigo ^a   Chapman, Thomas E ^b   Pereira, Henrique ^c   Oliveira, Giselle C ^c   Illanes, Renata P ^c   Fernandes, Telma F ^c   Azevedo, Débora A ^c   Neto, Francisco Aquino ^c  

^a HOUSE EAR INSTITUTE   (United States)

^b ALLERGAN INC   (United States)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

13C 12C; Combustion; Confirmation; Doping; Gas chromatography; Isotope ratio mass spectrometry; Pan American Games; Steroids

Indexed keywords

5BETA ANDROSTANE DERIVATIVE; ANDROSTANEDIOL; ANDROSTERONE; CARBON 13; EPITESTOSTERONE; ETIOCHOLANOLONE; STEROID;

ALDOSTERONE URINE LEVEL; ARTICLE; ATHLETE; BRAZIL; CLINICAL TRIAL; COMPETITION; CONTROLLED STUDY; DOPING; DRUG SCREENING; FEMALE; GAME; HORMONE DETERMINATION; HUMAN; MALE; MASS FRAGMENTOGRAPHY; METABOLITE; MULTICENTER STUDY; STEROID ANALYSIS; STEROID URINE LEVEL; URINALYSIS;

ANABOLIC AGENTS; ANDROSTANOLS; ANDROSTERONE; BRAZIL; CARBON ISOTOPES; CHROMATOGRAPHY, GAS; DOPING IN SPORTS; ESTROGENS; ETIOCHOLANOLONE; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; QUALITY CONTROL; SPECIMEN HANDLING; SUBSTANCE ABUSE DETECTION; TESTOSTERONE;

EID: 67349288067     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2009.03.012     Document Type: Article

References (46)

1. World Anti-Doping Agency, The World Anti-Doping Code, www.wada-ama.org.
2. Donike M., Adamietz B., Opfermann G., Schanzer W., Zimmerman J., and Mandel F. Die Normbereiche fur Testostero- und Epitestosterone Urinspiegel sowie des Testosteron-/Epitestosteron-Quotienten. In: Franz I.W., Mellerowicz H., and Noack W. (Eds). Training und Sport Pravention und Rehabilitation in der Technisierten Umwelt (1985), Springer Verlag, Berlin 503-507
3. Donike M., Rauth S., and Wolansky A. Reference ranges of urinary endogenous steroids determined by gas chromatography/mass spectrometry. In: Donike M., Goyer H., Gotzmann A., Mareck-Engelke U., and Rauth S. (Eds). Proceedings of the 10th Cologne Workshop on Dope Analysis (1993), Sport und Buch Strauss, Koln 69-86
4. Catlin D.H., and Hatton C.K. Use and abuse of anabolic and other drugs for athlete enhancement. Adv. Intern. Med. 36 (1991) 399-424
5. Dehenin L., and Matsumoto A.M. Long-term administration of testosterone enanthate to normal men: alterations of the urinary profile of androgen metabolites potentially useful for detection of testosterone misuse in sport. J. Steroid Biochem. Mol. Biol. 44 (1993) 179-189
6. Palonek E., Gottlieb C., Garle M., Bjorkhem I., and Carlstrom K. Serum and urinary markers of exogenous testosterone administration. J. Steroid Mol. Biol. 55 (1995) 121-127
7. de la Torre X., Segura J., Yang Z., Li Y., and Wu M. Testosterone detection in different ethnic groups. In: Schanzer W., Gotzman A., and Mareck-Engelke U. (Eds). Recent Advances in Doping Analysis (1997), Sport und Buch Strauss, Koln 71-79
8. Park J., Park S., Lho D., Choo H.P., Chung B., Yoon C., Min H., and Choi M.J. 1990 drug testing at the 10th Asian Games and 24th Seoul Olympic Games. J. Anal. Toxicol. 14 (1990) 66-72
9. WADA Laboratory Committee, Reporting and Evaluation Guidance for Testosterone, Epitestosterone, T/E Ratio and Other Endogenous Steroids, World Anti Doping Agency, Montreal, WADA document TD2004EAAS, 2004. http://www.wada-ama.org/rtecontent/document/end/steroids/aug_04.pdf, September 2007.
10. Brooks J. Consensus on doping policy may be legacy of Nagano games. JAMC 159 (1998) 438
11. 12C isotope ratio MS analysis of testosterone, in chemicals and pharmaceutical preparations. J. Pharm. Biomed. Anal. 24 (2001) 645-650
12. Becchi M., Aguilera R., Farizon Y., Flament M.-M., Casabianca H., and James P. Gas chromatography/combustion/isotope-ratio mass spectrometry analysis of urinary steroids to detect misuse of testosterone in sport. Rapid Commun. Mass Spectrom. 8 (1994) 304-308
13. Ueki M., and Okano M. Analysis of exogenous dehydroepiandrosterone excretion in urine by gas chromatography/combustion/isotope ratio mass spectrometry. Rapid Commun. Mass Spectrom. 13 (1999) 2237-2243
14. Meier-Augenstein W. The chromatographic side of isotope ratio mass spectrometry: pitfalls and answers. LC-GC International (1997) 17-25
15. Meier-Augenstein W. Applied gas chromatography coupled to isotope ratio mass spectrometry. J. Chromatogr. A 842 (1999) 351-371
16. Craig H. Isotopic standards for carbon and oxygen and correction factors for mass-spectrometric analysis of carbon dioxide. Geochim. Cosmochim. Acta 12 (1957) 133-149
17. 13C-values of endogenous urinary steroids. Steroids 73 (2008) 408-416
18. Maître A., Saudan C., Mangin P., and Saugy M. Urinary analysis of four testosterone metabolites and pregnanediol by gas chromatography/combustion/isotope ratio mass spectrometry after oral administrations of testosterone. J. Anal. Toxicol. 28 (2004) 426-431
19. Aguilera R., Catlin D.H., Becchi M., Phillips A., Wang C., Swerdloff R.S., Pope H.G., and Hatton C.K. Screening urine for exogenous testosterone by isotope ratio mass spectrometric analysis of one pregnanediol and two androstanediols. J. Chromatogr. B 727 (1999) 95-105
20. Shackleton C.H.L., Phillips A., Chang T., and Li Y. Confirming testosterone administration by isotope ratio mass spectrometric analysis of urinary androstanediols. Steroids 62 (1997) 379-387
21. Horning S., Geyer H., Machnnik M., Schanzer S., Hilkert A., and Oebelmann J. In: Schanzer W., Geyer H., Gotzmann A., and Mareck-Engelke U. (Eds). Recent Advances in Doping Analysis (1997), Sport und Buch Strauss, Koln 275
22. 13C (‰) values by gas chromatography/combustion/isotope ratio mass spectrometry. Rapid Commun. Mass Spectrom. 14 (2000) 2294-2299
23. Mareck U., Geyer H., Flenker U., Piper T., Thevis M., and Schänzer W. Detection of dehydroepiandrosterone misuse by means of gas chromatography-combustion-isotope ratio mass spectrometry. Eur. J. Mass Spectrom. 13 (2007) 419-426
24. Aguilera A., Becchi M., Casabianca H., Hatton C.K., Catlin D.H., Starcevic B., et al. Improved method of detection of testosterone abuse by gas chromatography/combustion/isotope ratio mass spectrometry analysis of urinary steroids. J. Mass Spectrom. 31 (1996) 169-176
25. 12C ratio. Steroids 71 (2006) 364-370
26. Aguilera R., Chapman T.E., Starcevic B., Hatton C.K., and Catlin D.H. Performance characteristics of a carbon isotope ratio method for detecting doping with testosterone based on urine diols: controls and athletes with elevated testosterone/epitestosterone ratios. Clin. Chem. 47 (2001) 292-300
27. Maître M., Saudan C., Mangin P., and Saugy M. Urinary analysis of four testosterone metabolites and pregnanediol by gas chromatography/combustion/isotope ratio mass spectrometry after oral administrations of testosterone. J. Anal. Toxicol. 28 (2004) 426-431
28. Saudan C., Baume N., Mangin P., and Saugy M. Urinary analysis of 16(5alpha)-androsten-3alpha-ol by gas chromatography/combustion/isotope ratio mass spectrometry: implications in anti-doping analysis. J. Chromatogr. B 810 (2004) 157-164
29. Shackleton C.H.L., Roitman E., Phillips A., and Chang T. Androstanediol and 5-androstenediol profiling for detecting exogenously administered dihydrotestosterone, epitestosterone, and dehydroepiandrosterone: potential use in gas chromatography isotope ratio mass spectrometry. Steroids 62 (1997) 665-673
30. Cawley A.T., Hine E.R., Trout G.J., George A.V., and Kazlauskas R. Searching for new markers of endogenous steroid administration in athletes: "looking outside the metabolic box". Forensic Sci. Int. 143 (2004) 103-114
31. Cawley A.T., Kazlauskas R., Trout G.J., Rogerson J.H., and George A.V. Isotopic fractionation of endogenous anabolic androgenic steroids and its relationship to doping control in sports. J. Chromatogr. Sci. 43 (2005) 32-38
32. Aguilera R., Hatton C.K., and Catlin D.H. Detection of epitestosterone doping by isotope ratio mass spectrometry. Clin. Chem. 48 (2002) 629-636
33. Mathurin J.C., Herrou V., Bourgogne E., Pascaud L., and de Ceaurriz J. Gas chromatography-combustion-isotope ratio mass spectrometry analysis of 19-norsteroids: application to the detection of a nandrolone metabolite in urine. J. Chromatogr. B 759 (2001) 267-275
34. Bourgogne E., Herrou V., Mathurin J.C., Becchi M., and de Ceaurriz J. Detection of exogenous intake of natural corticosteroids by gas chromatography/combustion/isotope ratio mass spectrometry: application to misuse in sport. Rapid Commun. Mass Spectrom. 14 (2000) 2343-2347
35. Saudan C., Desmarchelier A., Sottas P.E., Mangin P., and Saugy M. Urinary marker of oral pregnenolone administration. Steroids 70 (2005) 179-183
36. Saudan C., Augsburger M., Mangin P., and Saugy M. Carbon isotopic ratio analysis by gas chromatography/combustion/isotope ratio mass spectrometry for the detection of gamma-hydroxybutyric acid (GHB) administration to humans. Rapid Commun. Mass Spectrom. 21 (2007) 3956-3962
37. 12C ratios of endogenous urinary steroids: method validation, reference population and application to doping control purposes. Rapid Commun. Mass Spectrom. 22 (2008) 2161-2175
38. Saudan C., Kamber M., Barbati G., Robinson N., Desmarchelier A., Mangin P., and Saugy M. Longitudinal profiling of urinary steroids by gas chromatography/combustion/isotope ratio mass spectrometry: diet change may result in carbon isotopic variations. J. Chromatogr. B 831 (2006) 324-327
39. Cawley A.T., and Flenker U. The application of carbon isotope ratio mass spectrometry to doping control. J. Mass Spectrom. 43 (2008) 854-864
40. Quality Assurance of Chemical Measurements, John Keenan Taylor, Lewis Publishers, 1987, Chapter 14 Control Charts.
41. Rautenschlein M., Habfast K., and Brand W. In: Chapman T.E., Berger R., Reijngoud D.J., and Okken A. (Eds). Stable Isotopes in Paediatric, Nutritional and Metabolic Research (1990), Intercept Ltd., Andover, UK 133-148
42. Matucha M., Jockisch W., Verner P., and Anders G. Isotope effect in gas-liquid chromatography of labeled compounds. J. Chromatogr. 588 (1991) 251-258
43. Jakobsson J., Ekström L., Inotsume N., Garle M., Lorentzon M., Ohlsson C., Roh H.K., Carlström K., and Rane A. Large differences in testosterone excretion in Korean and Swedish men are strongly associated with a UDP-glucuronosyl transferase 2B17 polymorphism. J. Clin. Endocrinol. Metab. 91 (2006) 687-693
44. Jakobsson Schulze J., Lundmark J., Garle M., Skilving I., Ekström L., and Rane A. Doping test results dependent on genotype of UGT2B17, the major enzyme for testosterone glucuronidation. J. Clin. Endocrinol. Metab. (2008)
45. Sottas P.E., Saudan C., Schweizer C., Baume N., Mangin P., and Saugy M. From population- to subject-based limits of T/E ratio to detect testosterone abuse in elite sports. Forensic Sci. Int. 174 (2008) 166-172
46. Pereira H.M.G., Padilha M.C., Bento R.M.A., Cunha T.P., Lascas N.A.G., and Aquino Neto F.R. Analytical and logistical improvements in doping-control analysis at the 2007 Pan-American Games. Trends in Anal. Chem. (TRAC) 27 (2008) 648-656